Stockwinners Market Radar for July 04, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
ALNY | Hot Stocks17:59 EDT Alnylam says Apollo Phase 3 trial of patisiran published in NEJM - Alnylam Pharmaceuticals announced that the pivotal study results from the Apollo Phase 3 trial of patisiran were published online today in The New England Journal of Medicine. The study showed that patisiran improved measures of polyneuropathy, quality of life, activities of daily living, ambulation, nutritional status, and autonomic symptoms relative to placebo in patients with hereditary transthyretin-mediated amyloidosis, the company said. Patisiran treatment also led to favorable effects on exploratory endpoints related to cardiac structure and function in patients with cardiac involvement, it added. Further, the frequency and severity of adverse events were similar in patients receiving patisiran and placebo, with the exception of peripheral edema and infusion-related events which were higher in patisiran-treated patients and generally mild to moderate in severity. "We are extremely pleased with the publication of this landmark manuscript, the first-ever pivotal RNAi clinical trial to be published in a top-tier, peer-reviewed medical journal," said Akshay Vaishnaw, President of Research and Development at Alnylam.
|
OMAB | Hot Stocks17:57 EDT OMA Airports reports June passenger traffic up 9.1% - OMA Airports reports that terminal passenger traffic at its 13 airports increased 9.1% in June 2018, as compared to June 2017. Domestic traffic increased 9.9%, and international traffic increased 3.2%.
|
EXEL | Hot Stocks17:56 EDT Exelixis says Celestial Phase 3 results published in NEJM - Exelixis announced that The New England Journal of Medicine published results from the Celestial Phase 3 pivotal trial of cabozantinib in patients with previously treated advanced hepatocellular carcinoma.1 The data, originally presented at the 2018 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium in January, demonstrate that cabozantinib provided a statistically significant and clinically meaningful improvement in overall survival versus placebo, the company said in a statement. Median overall survival in Celestial was 10.2 months with cabozantinib versus 8.0 months with placebo. Median progression-free survival was more than doubled, at 5.2 months with cabozantinib and 1.9 months with placebo. "Patients with this form of advanced liver cancer have very limited treatment options once their disease progresses following treatment with sorafenib," said Ghassan K. Abou-Alfa, M.D., Memorial Sloan Kettering Cancer Center, New York and lead investigator on Celestial. "These results suggest that, if approved, cabozantinib could become an important addition to the treatment landscape that may help slow disease progression and, critically, improve survival for these patients."
|
BIP ENB | Hot Stocks09:10 EDT Brookfield Infrastructure acquires Enbridge's Canadian midstream unit for $3.3B - Brookfield Infrastructure (BIP) and its institutional partners announced that it has entered into a definitive agreement to acquire 100% of Enbridge's (ENB) Western Canadian natural gas gathering and processing business for an enterprise value of C$4.31B, or approximately $3.3B. Brookfield Infrastructure's equity commitment towards the investment will be approximately $500M, representing an approximate 30% interest in the business. Brookfield Infrastructure will fund its share of the transaction with its available liquidity comprised of, among other things, proceeds from the sale of its interest in Transelec, which closed in March 2018. "This investment represents an exciting opportunity to invest in scale in one of North America's leading gas gathering and processing businesses based in Western Canada. The business is strategically positioned for the continued development of the prolific Montney Basin," said Sam Pollock, CEO of Brookfield Infrastructure. "Cash flows from the business are anchored by a firm contract profile with a weighted average life of 10 years." The Canadian Midstream Business includes 19 natural gas processing facilities with total operating processing capacity of 3.3 Bcf/d and 3,550 kilometers of gathering pipelines, with connectivity to major demand markets including the U.S. Pacific Northwest, U.S. Midwest and Western Canada. The transaction is expected to close in two phases, with the facilities subject to provincial regulation expected to achieve financial close in 2018 and closing of those subject to federal regulation anticipated in mid-2019.
|
ENB BIP | Hot Stocks09:07 EDT Enbridge sells Canadian natural gas gathering unit to Brookfield for C$4.31B - Enbridge (ENB) announced that it has entered into definitive agreements to sell its Canadian natural gas gathering and processing business in the Montney, Peace River Arch, Horn River and Liard basins in British Columbia and Alberta to Brookfield Infrastructure (BIP) and its institutional partners for a cash purchase price of C$4.31B, subject to customary closing adjustments and receipt of regulatory approvals. The G&P Business includes 19 natural gas processing plants and liquids handling facilities, with a total operating capacity of 3.3 Bcf/d and 3,550 km of natural gas gathering pipelines. Separate sale agreements have been entered into for those facilities currently governed by provincial regulations, and those governed by federal National Energy Board regulations. The transaction involving the sale of the provincially regulated facilities is expected to close in 2018, while the transaction involving the sale of the federally regulated facilities is anticipated to close in mid-2019. Enbridge said, "Proceeds from these transactions provide significant additional financing flexibility going forward as the Company continues to execute on its current portfolio of secured growth projects. The Company's outlook for DCF/share through 2020 and its target credit metrics remain unchanged as a result of these asset sales." The company will continue to hold its long haul regulated natural gas transmission assets which include the Westcoast transmission system in British Columbia and the Alliance pipeline that carries natural gas from western Canada to the Chicago market.
|
CAG | Hot Stocks08:49 EDT Conagra Brands completes $32M sale of Canadian Del Monte unit - Conagra Brands announced that it has completed the divestiture of its Canadian Del Monte processed fruit and vegetable business to Bonduelle Group. The transaction is valued at approximately C$43M, which is approximately $32M at the current exchange rate.
|
CAG | Hot Stocks08:41 EDT Conagra Brands completes $32M sale of Canadian Del Monte unit - Conagra Brands announced that it has completed the divestiture of its Canadian Del Monte processed fruit and vegetable business to Bonduelle Group. The transaction is valued at approximately C$43, which is approximately $32M at the current exchange rate.
|
INTC BIDU | Hot Stocks08:39 EDT Baidu to integrate Intel's Mobileye on open source Project Apollo - Baidu (BIDU) announced that it plans to work with Intel's (INTC) Mobileye to integrate and commercially deploy Mobileye's Responsibility Sensitive Safety model in both the open source Project Apollo and commercial Apollo Pilot programs, Intel said in a statement. Baidu also announced plans to adopt Mobileye's Surround Computer Vision Kit as the visual perception solution; it will be integrated as part of Baidu's proposition to the Chinese OEM market, the company added. Intel said, "The safety collaboration between Mobileye, an Intel Company, and Baidu is a significant strategic success for Mobileye's RSS model, which was published last year, and will help deliver a safe driving solution for autonomous vehicles on China's challenging roadways."
|
FIZZ | Hot Stocks08:37 EDT National Beverage, CEO 'unequivocally deny' sexual harassment allegations - National Beverage Corp. late last night released the following statement: "National Beverage Corp. and Nick Caporella completely and unequivocally deny the allegations recited in today's Wall Street Journal. 'There is no truth to any of the allegations and nothing remotely akin to the alleged events occurred,' the Company stated. 'The allegations, which were lifted from employment-related lawsuits filed by two former associates, are contrary to the statements of many others who have known and flown with Mr. Caporella for decades. The Journal reporter chose to recklessly disregard documentary evidence that refuted the allegations that were the subject of the report.' Samuel Hathorn, chairman of the Company's Audit Committee, stated, 'The Board is aware of the allegations and knows them to be untrue, based on our knowledge of Mr. Caporella and the investigation that was conducted.'" The Wall Street Journal yesterday afternoon reported that two pilots and former employees filed lawsuits alleging sexual harassment against National Beverage Chairman and CEO Nick Caporella over the past two years. Shares of National Beverage, maker of LaCroix sparkling water, closed yesterday up $2.00 to $109.94.
|